BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26822627)

  • 1. Editorial Comment from Dr Sakano and Dr Matsuyama to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Sakano S; Matsuyama H
    Int J Urol; 2016 Mar; 23(3):231-2. PubMed ID: 26822627
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial Comment from Dr Miyata and Dr Sakai to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Miyata Y; Sakai H
    Int J Urol; 2016 Mar; 23(3):230-1. PubMed ID: 26840209
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Inokuchi J; Naito S; Fujimoto H; Hara T; Sakura M; Nishiyama H; Miyazaki J; Kikuchi E; Hinotsu S; Koie T; Ohyama C;
    Int J Urol; 2016 Mar; 23(3):224-30. PubMed ID: 26659912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial Comment from Dr Haddad and Dr Margulis to Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
    Haddad AQ; Margulis V
    Int J Urol; 2015 Nov; 22(11):1022. PubMed ID: 26499874
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment from Dr Kim and Dr Ku to Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
    Kim HS; Ku JH
    Int J Urol; 2015 Nov; 22(11):1021. PubMed ID: 26238808
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial Comment to Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi-institutional national database.
    Kondo T
    Int J Urol; 2015 Nov; 22(11):1027-8. PubMed ID: 26278279
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
    Hara T; Fujimoto H; Sakura M; Inokuchi J; Nishiyama H; Miyazaki J; Ohyama C; Koie T; Kikuchi E; Hinotsu S;
    Int J Urol; 2015 Nov; 22(11):1013-20. PubMed ID: 26242807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi-institutional national database.
    Miyazaki J; Nishiyama H; Fujimoto H; Ohyama C; Koie T; Hinotsu S; Kikuchi E; Sakura M; Inokuchi J; Hara T;
    Int J Urol; 2015 Nov; 22(11):1023-7. PubMed ID: 26238570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Comment from Dr Lonati and Dr Moschini to Stage and cancer-specific mortality differ within specific Asian ethnic groups in upper tract urothelial carcinoma: North American population-based study.
    Lonati C; Moschini M
    Int J Urol; 2021 Dec; 28(12):1252-1253. PubMed ID: 34580928
    [No Abstract]   [Full Text] [Related]  

  • 10. Laparoscopic Versus Open Nephroureterectomy in Muscle-Invasive Upper Tract Urothelial Carcinoma: Subanalysis of the Multi-Institutional National Database of the Japanese Urological Association.
    Miyazaki J; Nishiyama H; Fujimoto H; Ohyama C; Koie T; Hinotsu S; Kikuchi E; Sakura M; Inokuchi J; Hara T
    J Endourol; 2016 May; 30(5):520-5. PubMed ID: 26669358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial Comment from Dr Shiota to Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study.
    Shiota M
    Int J Urol; 2021 Dec; 28(12):1253. PubMed ID: 34545645
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial Comment to Risk stratification using Bmi-1 and Snail expression is a useful prognostic tool for patients with upper tract urothelial carcinoma.
    Matsumoto R
    Int J Urol; 2016 Dec; 23(12):1037. PubMed ID: 27804196
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial Comment from Dr Setoguchi and Dr Saito to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
    Setoguchi K; Saito K
    Int J Urol; 2021 Aug; 28(8):821-822. PubMed ID: 34169599
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial Comment to Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes.
    Urakami S; Okaneya T
    Int J Urol; 2016 Feb; 23(2):158-9. PubMed ID: 26663568
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial Comment from Dr Sazuka to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
    Sazuka T
    Int J Urol; 2021 Aug; 28(8):820-821. PubMed ID: 34013556
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
    Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
    J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we improve the biopsy quality of upper urinary tract urothelial tumors? Single-center preliminary results of a new biopsy forceps.
    Al-Qahtani SM; Legraverend D; Gil-Diez de Medina S; Sibony M; Traxer O
    Urol Int; 2014; 93(1):34-7. PubMed ID: 24642765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.